Yahoo Web Search

  1. Ads
    related to MERCK & CO., INC
  1. Merck & Co Inc on Tuesday said it expected immunotherapy Keytruda to continue its market dominance as an initial treatment for advanced lung cancer as sales of the drug ...

  2. Stocks recently featured in the blog include: Pfizer PFE, Merck MRK, Bristol-Myers BMY and Glaxo GSK. Pfizer, Merck, Bristol-Myers, Glaxo and Bayer released their third-quarter ...

  3. Should You Worry About Merck & Co., Inc.'s (NYSE:MRK) CEO Salary Level?

    Simply Wall St. via Yahoo FinanceNov 12 19:47 PM

    Ken Frazier became the CEO of Merck & Co., Inc. (NYSE:MRK) in 2011. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at other ...

  4. Wall St. dips after S&P notches record, Fed on deck

    Reuters via Yahoo FinanceOct 29 11:52 AM

    The S&P 500 edged lower to snap a four-session win streak on Tuesday and it retreated from a record high as investors grappled with a flood of earnings and the latest update on a potential trade ...

  5. US STOCKS-Wall St holds steady after S&P hits record

    Reuters via Yahoo FinanceOct 29 18:57 PM

    The S&P 500 eased back from a record high on Tuesday to trade near the unchanged mark as investors weaved through the heart of earnings season and the latest headlines on a potential trade deal ...

  6. The market seems to have made up its mind a long time ago about what the Fed is likely to do this afternoon, so the rate decision this afternoon seems almost pre-ordained. The Fed decision dominates ...

  7. Edited Transcript of MRK earnings conference call or presentation 29-Oct-19 12:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceNov 01 0:31 AM

    Q3 2019 Merck & Co Inc Earnings Call WHITEHOUSE STATION Oct 31, 2019 (Thomson StreetEvents) -- Edited Transcript of Merck & Co Inc earnings conference ...

  8. Value Biotech ETFs & Stocks to Buy Now

    Zacks via Yahoo FinanceNov 04 18:00 PM

    There were other announcements like Roche's RHHBY acquisition of Spark Therapeutics for $4.8 billion and Merck's MRK acquisition of Immune Design.

  9. Earnings, clinical trial readouts and positive FDA verdicts catalyzed fairly robust performances by biotech stocks last week. Biogen Inc (NASDAQ: BIIB )'s about-face with respect to its Alzheimer's drug ...

  10. WeTrader Competition: Round Four Wrap-up

    Benzinga via Yahoo FinanceNov 01 21:15 PM

    The top 10 performing portfolios each week will receive an, Inc.

  1. Ads
    related to MERCK & CO., INC